Hyperion DeFi HYPD Complete Analysis Q4 2025 EPS Misses Views Northern NOG Stock Breakout Zone At Lows 20260427 Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia